Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California).

scientific article published on 23 May 2006

Proceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California). is …
instance of (P31):
scholarly articleQ13442814

External links are
P698PubMed publication ID16735995

P50authorMagali Saint-GeniezQ58898025
Wen-Tao DengQ73592324
Maria B GrantQ88523403
P2093author name stringArnall Patz
Kenneth I Berns
Gerard A Lutty
Tailoi Chan-Ling
David R Hinton
Martin Friedlander
Bradley T Smith
Michael X Repka
William Tasman
Lois E H Smith
John T Flynn
William W Hauswirth
Patricia A D'Amore
Robert J Hardy
Velma Dobson
William V Good
Dale L Phelps
David T Shima
Brian J Raisler
John S Penn
Candy K Chan
D Scott McLeod
Earl A Palmer
Suzanne Hughes
Anthony P Adamis
Lynn C Shaw
Arup Das
Michael T Trese
Cynthia H Cole
Anne Fulton
Ronald Hansen
Sjakon G Tahija
P921main subjectCaliforniaQ99
retinopathy of prematurityQ1423087
P304page(s)532-580
P577publication date2006-05-23
P1433published inMolecular VisionQ6895981
P1476titleProceedings of the Third International Symposium on Retinopathy of Prematurity: an update on ROP from the lab to the nursery (November 2003, Anaheim, California)
P478volume12

Reverse relations

cites work (P2860)
Q34642841Capillary-free vascularized retina in patients with aggressive posterior retinopathy of prematurity and late retinal capillary formation
Q37819879Current update on retinopathy of prematurity: screening and treatment
Q35221047Effect of VEGF trap on normal retinal vascular development and oxygen-induced retinopathy in the dog.
Q33431318Emerging treatments for retinopathy of prematurity
Q28583644Expression of vascular endothelial growth factor and pigment epithelial-derived factor in a rat model of retinopathy of prematurity
Q33873875Intravitreal bevacizumab in retinopathy of prematurity: an interventional case series.
Q41015495Many Faces of Renin-angiotensin System - Focus on Eye.
Q37648731PEDF mediates pathological neovascularization by regulating macrophage recruitment and polarization in the mouse model of oxygen-induced retinopathy.
Q37566578Pattern of blood vessels in eyes with coloboma
Q33606227Retinopathy of prematurity: current concepts in molecular pathogenesis
Q34090125Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life
Q33852745Screening of retinopathy of prematurity: a neglected public health issue
Q37462599TRAIL-deficient mice exhibit delayed regression of retinal neovascularization
Q90638487Targeting Neuroinflammation in Neovascular Retinal Diseases
Q38939564The Nicotinic Cholinergic Pathway Contributes to Retinal Neovascularization in a Mouse Model of Retinopathy of Prematurity
Q38110390The biology of retinopathy of prematurity: how knowledge of pathogenesis guides treatment
Q35768528The genetic control of avascular area in mouse oxygen-induced retinopathy
Q35877484The matricellular protein CCN1 controls retinal angiogenesis by targeting VEGF, Src homology 2 domain phosphatase-1 and Notch signaling.
Q37599582The significance of neuronal and glial cell changes in the rat retina during oxygen-induced retinopathy
Q91796363Three-dimensional pattern of extraretinal neovascular development in retinopathy of prematurity
Q34582020Visual disabilities in children including childhood blindness

Search more.